We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$17.4B
AUM Growth
+$359M
(+2.1%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
357
New
45
Increased
93
Reduced
141
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$141M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$129M |
| 3 |
Biogen
BIIB
|
+$126M |
| 4 |
United Therapeutics
UTHR
|
+$124M |
| 5 |
Whirlpool
WHR
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$274M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$207M |
| 3 |
SHPG
Shire pic
SHPG
|
+$206M |
| 4 |
MWIV
MWI VETERINARY SUPPLY, INC.
MWIV
|
+$137M |
| 5 |
JPMorgan Chase
JPM
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.8% |
| 2 | Technology | 14.71% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.27% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Colgate-Palmolive
CL
$74.4B
| $202K | ﹤0.01% |
2,910
| – | – |
|
302
Abbott
ABT
$187B
| – | – |
-57,010
| Closed | -$2.57M |
|
303
Archer Daniels Midland
ADM
$36.9B
| – | – |
-37,270
| Closed | -$1.94M |
|
304
Albemarle
ALB
$15.5B
| – | – |
-242,867
| Closed | -$14.6M |
|
305
Bath & Body Works
BBWI
$4.1B
| – | – |
-33,473
| Closed | -$2.34M |
|
306
B&G Foods
BGS
$286M
| – | – |
-1,455,372
| Closed | -$43.5M |
|
307
Benchmark Electronics
BHE
$2.96B
| – | – |
-998,614
| Closed | -$25.4M |
|
308
Celanese
CE
$4.82B
| – | – |
-2,019,602
| Closed | -$121M |
|
309
Coherus Oncology
CHRS
$196M
| – | – |
-778,041
| Closed | -$12.7M |
|
310
Chevron
CVX
$366B
| – | – |
-2,000
| Closed | -$224K |
|
311
Deckers Outdoor
DECK
$13.3B
| – | – |
-4,610,154
| Closed | -$70M |
|
312
Intel
INTC
$513B
| – | – |
-91,212
| Closed | -$3.31M |
|
313
ITT
ITT
$19.1B
| – | – |
-509,330
| Closed | -$20.6M |
|
314
iShares Russell 1000 Growth ETF
IWF
$128B
| – | – |
-30,656
| Closed | -$733K |
|
315
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| – | – |
-6,770
| Closed | -$316K |
|
|
JNPR
316
DELISTED
Juniper Networks
JNPR
| – | – |
-1,617,077
| Closed | -$36.1M |
|
|
317
JPMorgan Chase
JPM
$950B
| – | – |
-2,113,574
| Closed | -$132M |
|
318
Lockheed Martin
LMT
$136B
| – | – |
-1,150
| Closed | -$221K |
|
319
LPL Financial
LPLA
$28.6B
| – | – |
-341,875
| Closed | -$15.2M |
|
320
MetLife
MET
$62.4B
| – | – |
-37,116
| Closed | -$1.79M |
|
321
Martin Marietta Materials
MLM
$33B
| – | – |
-246,203
| Closed | -$27.2M |
|
322
NOV
NOV
$7B
| – | – |
-1,900,822
| Closed | -$125M |
|
323
Oil States International
OIS
$491M
| – | – |
-326,711
| Closed | -$16M |
|
324
Polaris
PII
$4.07B
| – | – |
-381,917
| Closed | -$57.8M |
|
325
Douglas Dynamics
PLOW
$1.02B
| – | – |
-35,300
| Closed | -$756K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Westfield Capital Management held 357 positions worth $17.4B, up 2.1% from $17B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q1 2015 filing shows 45 new, 93 increased, 141 reduced and 56 closed positions. Its largest new stake was Mastercard: 1,619,899 shares worth $140M. The largest sale was CUBIST PHARMACEUTICALS INC, an estimated $274M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q1 2015 buy was Mastercard: 1,619,899 shares worth $140M.
- Westfield Capital Management added most to Biogen in Q1 2015, an estimated $126M increase.
- Westfield Capital Management's biggest Q1 2015 reduction was Shire pic, cutting an estimated $206M.
- Westfield Capital Management fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $274M.
- Westfield Capital Management's ten largest holdings make up 19% of its $17.4B portfolio in Q1 2015.
- Westfield Capital Management opened 45 new positions and closed 56 in Q1 2015.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $17.4B.
Based on Westfield Capital Management's 13F filing for Q1 2015, filed 13 May 2015.